Implantation of a dual chamber pacemaker defibrillator in a patient with hypertrophic obstructive cardiomyopathy;Implantation eines zwei-kammer-schrittmacher-defibrillators (DDD-ICD) bei einer patientin mit hypertropher obstruktiver kardiomyopathie

Zeitschrift fur Kardiologie

Volumn 88, Issue 7, 1999, Pages 521-525

  Neuberger, H R ^a   Mewis, C ^a   Dornberger V ^a   Bosch, R F ^a   Kuhlkamp V ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Dual chamber pacing; Hypertrophic obstructive cardiomyopathy; Implantable cardioverter defibrillator; Ventricular tachyarrhythmias

Indexed keywords

AGED; ANGINA PECTORIS; ARTICLE; CASE REPORT; DEFIBRILLATOR; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE OUTFLOW TRACT; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; SUDDEN DEATH; SYNCOPE;

AGED; CARDIOMYOPATHY, HYPERTROPHIC; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ELECTROCARDIOGRAPHY; EQUIPMENT DESIGN; FEMALE; HUMANS; PACEMAKER, ARTIFICIAL; SYNCOPE; TACHYCARDIA, VENTRICULAR;

EID: 0032791531     PISSN: 03005860     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003920050317     Document Type: Article

References (21)

1. Betocchi S, Lost MA, Piscione F, et al (1996) Effects of dual-chamber pacing in hypertrophic cardiomyopathy on left ventricular outflow tract obstruction and on diastolic function. Am J Cardiol 77:498-502
2. Borggrefe M, Breithardt G (1998) Is the implantable defibrillator indicated in patients with hypertrophic cardiomyopathy and aborted sudden death? J Am Coll Cardiol 31:1086-1088
3. DeRose JJ Jr, Banas SR Jr, Winters SL (1994) Current perspectives of sudden cardiac death in hypertrophic cardiomyopathy. Prog Cardiovasc Dis 36:475-484
4. Fananpazir L, Chang AC, Epstein SE, McAreavey D (1992) Prognostic determinants in hypertrophic cardiomyopathy. Circulation 86:730-740
5. Fananpazir L, Epstein ND, Cuirel RV, Panza JA, Tripodi D, McAreavey D (1994) Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy: evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy. Circulation 90:2731-2742
6. Fananpazir L, McAreavey D (1997) Hypertrophic cardiomyopathy: evaluation and treatment of patients at high risk for sudden death. PACE 20:478-501
7. Haverkamp W, Eckardt L, Borggrefe M, Breithardt G (1997) Drugs versus devices in controlling ventricular tachycardia, ventricular fibrillation, and recurrent cardiac arrest. Am J Cardiol 80 (8A):67G-73G
8. Jeanrenaud X, Goy JJ, Kappenberger L (1992) Effects of dual-chamber pacing in hypertrophic obstructive cardiomyopathy. Lancet 339:1318-1323
9. Kappenberger L, Linde C, Daubert C, McKenna W, Meisel E, Sadoul N, Chojnowska L, Guize L, Gras D, Jeanrenaud X, Rydén L, and the PIC Study Group (1997) Pacing in hypertrophic obstructive cardiomyopathy. Eur Heart J 18:1249-1256
10. Kuck K-H (1997) Arrhythmias in hypertrophic cardiomyopathy. PACE 20:2706-2713
11. LaVergne T, Daubert JC, Chauvin M, et al (1997) Preliminary clinical experience with the first dual chamber pacemaker defibrillator. PACE 20:182-188
12. Maron BJ (1997) Hypertrophic cardiomyopathy. Lancet 350:127-133
13. Maron BJ, Bonow RO, Cannon RO, Leon MB, Epstein SE (1987) Hypertrophic cardiomyopathy: interrelation of clinical manifestations, pathophysiology, and therapy. N Engl J Med 316:780-789
14. McKenna WJ, Oakley CM, Krikler DM, Goodwin JF (1985) Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia. Br Heart J 53:412-416
15. Nishimura RA, Hayes DL, Ilstrup DM, Holmes DR, Talik AJ (1996) Effects of dual-chamber pacing on systolic and diastolic function in patients with hypertrophic cardiomyopathy: acute Doppler echocardiographic and catheterization hemodynamic study. J Am Coll Cardiol 27:421-430
16. Nishimura RA, Trusty JM, Hayes DL, et al (1997) Dual-chamber pacing for hypertrophic obstructive cardiomyopathy: a randomized, double-blind, crossover study. J Am Coll Cardiol 29:435-441
17. Rothlin M, Moccetti T (1967) Becinflussung der muskulären Subaortenstenose durch intrakavitäre Reizausbreitung. Verh Dtsch Ges Kreisl 37:411-415
18. Seggewiss H, Gleichmann U, Faber L, Fassbender D, Schmidt HK, Strick S (1997) Catheter treatment of hypertrophic obstructive cardiomyopathy: acute and mid-term results. J Am Coll Cardiol 29, Suppl A:388A. abstract
19. Seggewiss H, Gleichmann U, Faber L, Fassbender D, Schmidt HK, Strick S (1998) Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results and 3-month follow-up in 25 patients. J Am Coll Cardiol 31:252-258
20. Wigle ED, Rakowski H, Kimball BP, Williams WG (1995) Hypertrophic cardiomyopathy: clinical spectrum and treatment. Circulation 92:1680-1692
21. Zhu DWX, Sun H, Hil R, Roberts R (1998) The value of electrophysiology study and prophylactic implantation of cardioverter defibrillator in patients with hypertrophic cardiomyopathy. PACE 21:299-302